EndoBarrier Gastrointestinal Liner: Pilot trial data

Data from a pilot trial in 18 patients showed that EndoBarrier Gastrointestinal Liner reduced HbA1c by 1.3% and 2.4% from baseline to weeks 12 and 24 , respectively, vs. 0.7% and 0.8% for sham endosco...